Our Providers

Samuel Wentworth, M.D.

Specialties:
Diabetes Management

Education:
Medical School – Indiana University School of Medicine
Internship – Riley Hospital for Children
Residency – Riley Hospital for Children
Fellowship – Eli Lilly Clinic – Wishard Memorial Hospital

Groups:
Hendricks Regional Health Medical Group

Contact Info
Phone: (317) 745-7128
Fax: (317) 745-3085

Locations
Hendricks Regional Diabetes Health (Primary Location)
100 Hospital Lane, Suite 205
Building 3
Danville, IN 46122
View Map
Hours: M – F; 8 am – 4:30 pm

Advancing the Treatment of Diabetes

Dr. Samuel Wentworth has spent nearly four decades as a physician working to improve the lives of those with diabetes. He has contributed through volunteerism and a strong commitment to furthering research for advanced treatments. His efforts led to a 2005 LillyforLife Achievement Award in the “professional hero” category.

Diabetes Youth Foundation of Indiana

Diabetes Youth Foundation of Indiana (DYF) is a non-profit organization that provides camping experiences to Hoosier children to educate, support and encourage families managing Type 1 diabetes. Every summer, children ages 7 to 15 from throughout Indiana, swim, hike, explore creeks and climb ropes just like any other boy or girl at summer camp. They also poke, prick, test, count carbohydrates and learn what they need to do to live a vibrant, healthy life with diabetes. This relaxed, informal and peer-supported situation is ideal for teaching diabetes management techniques. Through DYF, Dr. Wentworth also helps provide educational experiences for children from Russia, Lithuania, Siberia and the Ukraine with diabetes.

Learn more about DYF or give online

Breakthrough in Monogenic Diabetes

Researchers reported a breakthrough discovery in diabetes research in August 2006. A British physician identified monogenic diabetes, a rare form of Type I diabetes caused by a single genetic mutation. This rare condition, occurring in approximately one out of every 200,000 births, is treatable by a family of drugs called sulfonylureas. The drug allows the body’s insulin-secreting cells to become active and some patients are able to stop using insulin injections in exchange for sulfonylureas, an oral medication typically taken twice each day.

Dr. Wentworth, a specialist in endocrinology, diabetes and metabolism at Hendricks Regional Diabetes Health, treated two patients, a mother and son, with monogenic diabetes. This pair was the first monogenic parent and child diabetes patients identified in the United States. Since the breakthrough study, Dr. Wentworth has identified additional patients in the U.S. with monogenic diabetes and is treating them with the new medication protocol.

Learn more about U.S. monogenic diabetes studies at The University of Chicago Diabetes Research and Training Center.